We are examining the effects of Saruparib and Darolutamide, both alone and together, in men with newly diagnosed prostate cancer. This research aims to understand how these treatments may impact patients before surgery.
Health conditions and diseases that the clinical trial is designed to study and treat.
Newly diagnosed prostate cancer refers to the initial detection of cancer in the prostate gland, which is a common type of cancer in men. It can lead to symptoms such as difficulty urinating, blood in urine, and pelvic discomfort.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.